Patent · US Expired

Preparation with an acrylic-based, adhesive copolymeric matrix for the transdermal delivery of estradiol

US6156335A · kind A · utility

10Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 1994
Grant dateDec 5, 2000
Priority date
Expiry dateJul 15, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is represented by a transdermal medicated patch for the extended release of 17.beta.-estradiol to the skin. The transdermal patch is formed by an outer covering, a matrix containing from 1% to 5% (w/w) 17.beta.-estradiol, and a protective liner which is removed before use. The matrix is formed of pressure-sensitive adhesive acrylic copolymers, in which the active ingredient is dissolved or dispersed. The acrylic copolymers are obtained by radical copolymerization of 2-ethylhexyl acrylate, methyl acrylate, acrylic acid, vinyl acetate, hydroxyethyl acrylate or a mixture thereof. Optionally quantities of less than 0.5% (w/w) of other substances may be added.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.